PFSA Profusa, Inc: Koefisien utang jangka dawa marang modal

The use of oxygen sensors in niche research is driving growth, which determines the long-term debt-to-equity trend, where the current level is around 0.00. Profusa Inc (PFSA) generates revenue from the regular replacement of biosensors, ensuring a stable cash flow. High physician confidence in non-invasive monitoring strengthens the position of the brand, which creates high-precision subcutaneous diagnostic systems.

PFSA - Utang jangka dawa marang ekuitas Profusa Inc. ing rentang 15.07.2025 - 28.10.2026

This indicator determines the share of long-term liabilities within the overall capital structure, assessing the company's financial leverage. For Profusa Inc (PFSA), this balance is critical amid the risk of electronics supply chain disruptions in Asia. By analyzing the current long-term debt-to-equity ratio, an investor can see the extent to which business development depends on borrowed funds. An increase in this metric signals heightened risks in the event of export restrictions, while a stable curve confirms the capital's resilience to geopolitical shocks.

Pesaing wigati

Rasio silihan jangka dawa marang modal DexCom Inc|Penumbra Corp (PEN) - Utang jangka dawa marang modal|Koefisien utang jangka dawa marang modal Novanta Photonics (NOVT)|HAE: Utang jangka dawa marang modal|inspiresleep.com - Kewajiban jangka dawa marang modal|Utang jangka dawa marang ekuitas PROCEPT BioRobotics Corporation (PRCT)|CNMD - Koefisien utang jangka dawa marang modal|PLSE: Utang jangka dawa marang modal|INMD (InMode MD) - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Picard Medical Inc PMI|Kewajiban jangka dawa marang ekuitas surmodics.com|Eversense - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal NeuroPace Inc NPCE|Rasio utang jangka dawa marang ekuitas TCMD (Tactile Medical)|SNWV - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Outset Medical, Inc. OM|ELMD - Rasio silihan jangka dawa marang modal|LENSAR - Utang jangka dawa marang modal|AVITA Medical Inc. (RCEL) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang modal PROF|Rasio utang jangka dawa marang ekuitas Baird Medical Corp (BDMD)|EDAP TMS S.A. (EDAP) - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal APYX (apyxmedical.com)|IceCure Medical - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas Pulmonx Corp LUNG|TELA (TELA Bio Corp) - Utang jangka dawa marang modal|CTSO - Kewajiban jangka dawa marang modal|Utang jangka dawa marang modal Sensus Healthcare, Inc.|zynex.com (ZYXI) - Rasio utang jangka dawa marang modal|ECOR: Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal Vicarious Surgical Corp|Utang jangka dawa marang modal IINN (Inspira Technologies Oxy)|Rasio utang jangka dawa marang ekuitas SeaStar Medical Holding Corp. (ICU)|Utang jangka dawa marang modal IRIX (IRIDEX)|Intelligent Bio Solutions Inc - Utang jangka dawa marang modal|XAIR - Utang jangka dawa marang ekuitas|STRATA Skin Sciences (SSKN) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas GlucoTrack GCTK|NanoVibronix Inc. (NAOV) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal VERO (Venus Concept Inc.)|Kewajiban jangka dawa marang modal NUWE|AEMD: Utang jangka dawa marang ekuitas|Tanggungan utang jangka dawa marang ekuitas asensus.com ASXC|Rasio utang jangka dawa marang ekuitas AVGR (Avinger, Inc)|Utang jangka dawa marang modal BioSig Technologies Inc. BSGM|Utang jangka dawa marang modal CUTR (Cutera, Inc.)|KNW: Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Inari Medical (NARI)|NVRO (Nevro Corp) - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas RSLS|Rasio utang jangka dawa marang ekuitas Silk Road Medical Inc